cariporide has been researched along with mocetinostat in 2 studies
| Studies (cariporide) | Trials (cariporide) | Recent Studies (post-2010) (cariporide) | Studies (mocetinostat) | Trials (mocetinostat) | Recent Studies (post-2010) (mocetinostat) |
|---|---|---|---|---|---|
| 409 | 10 | 79 | 21,735 | 390 | 8,606 |
| Protein | Taxonomy | cariporide (IC50) | mocetinostat (IC50) |
|---|---|---|---|
| Histone deacetylase 3 | Homo sapiens (human) | 0.7851 | |
| Nuclear receptor corepressor 1 | Homo sapiens (human) | 0.022 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.57 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.102 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.102 | |
| Histone deacetylase 4 | Homo sapiens (human) | 0.5717 | |
| Histone deacetylase 1 | Homo sapiens (human) | 0.3433 | |
| Histone deacetylase 7 | Homo sapiens (human) | 0.6725 | |
| Histone deacetylase 2 | Homo sapiens (human) | 0.3537 | |
| Histone deacetylase 11 | Homo sapiens (human) | 0.6386 | |
| Histone deacetylase 8 | Homo sapiens (human) | 0.6725 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.5717 | |
| Histone deacetylase 5 | Homo sapiens (human) | 0.6725 | |
| Nuclear receptor corepressor 2 | Homo sapiens (human) | 0.045 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buckberg, GD; Castellá, M; Ignarro, LJ; Tan, Z | 1 |
| Ashrafpour, H; Cahoon, NJ; Forrest, CR; Huang, N; Jindal, K; Lipa, JE; McAllister, SE; Moses, MA; Neligan, PC; Pang, CY | 1 |
2 other study(ies) available for cariporide and mocetinostat
| Article | Year |
|---|---|
Myocyte and endothelial effects of preconditioning the jeopardized heart by inhibiting Na/H exchange.
Topics: Animals; Anti-Arrhythmia Agents; Cardiopulmonary Bypass; Creatine Kinase; Creatine Kinase, MB Form; Endothelin-1; Guanidines; Ischemic Preconditioning, Myocardial; Isoenzymes; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Peroxidase; Sulfones; Swine; Time Factors | 2002 |
Na+/H+ exchange inhibitor cariporide attenuates skeletal muscle infarction when administered before ischemia or reperfusion.
Topics: Adenosine Triphosphate; Animals; Calcium; Castration; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Guanidines; Infarction; Injections, Intravenous; Mitochondria, Muscle; Muscle, Skeletal; Necrosis; Neutrophil Infiltration; Neutrophils; Peroxidase; Reperfusion Injury; Sodium-Hydrogen Exchangers; Sulfones; Surgical Flaps; Swine; Time Factors | 2009 |